Cogent Biosciences, Inc. (COGT) Deferred Tax Assets, Operating Loss Carryforwards

Cogent Biosciences, Inc. Deferred Tax Assets, Operating Loss Carryforwards

Cogent Biosciences, Inc. (COGT) had Deferred Tax Assets, Operating Loss Carryforwards of $100.59 million as of 2025-12-31, per its 10-K filed 2026-02-17.

Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-17

• 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $100.59M.
• 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $64.30M.
• 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $47.95M.
• 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $36.16M.